223 related articles for article (PubMed ID: 16332144)
41. [Recent advances of immune therapies for demyelinating neuropathies].
Ito H; Saito T
Rinsho Shinkeigaku; 1997 Dec; 37(12):1111-2. PubMed ID: 9577661
[TBL] [Abstract][Full Text] [Related]
42. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
Hughes RA
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
[TBL] [Abstract][Full Text] [Related]
43. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA
J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502
[TBL] [Abstract][Full Text] [Related]
44. Economic costs and quality of life in chronic inflammatory neuropathies in southeast England.
Mahdi-Rogers M; McCrone P; Hughes RA
Eur J Neurol; 2014; 21(1):34-9. PubMed ID: 23930744
[TBL] [Abstract][Full Text] [Related]
45. Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy.
Dalakas MC
Neurotherapeutics; 2021 Oct; 18(4):2397-2418. PubMed ID: 34766257
[TBL] [Abstract][Full Text] [Related]
46. 7(th) International Immunoglobulin Conference: Poster presentations.
Warnatz K; Ballow M; Stangel M; Bril V
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):139-40. PubMed ID: 25546796
[TBL] [Abstract][Full Text] [Related]
47. Treatment of Guillain-Barré syndrome and CIDP.
van Doorn PA
J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
[TBL] [Abstract][Full Text] [Related]
48. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
49. [Immunoglobulin therapy of neuromuscular diseases].
Schuchardt V
Nervenarzt; 1993 Feb; 64(2):91-7. PubMed ID: 8450900
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
van Doorn PA
Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
[TBL] [Abstract][Full Text] [Related]
51. Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update.
Nobile-Orazio E; Gallia F; Tuccillo F; Terenghi F
Curr Opin Neurol; 2010 Oct; 23(5):519-23. PubMed ID: 20689427
[TBL] [Abstract][Full Text] [Related]
52. Relapsing chronic low-dose corticosteroid-responsive multifocal motor neuropathy with conduction block.
de Carvalho M; Luís ML
Electromyogr Clin Neurophysiol; 1997 Mar; 37(2):95-7. PubMed ID: 9098673
[TBL] [Abstract][Full Text] [Related]
53. A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients.
Debs R; Reach P; Cret C; Demeret S; Saheb S; Maisonobe T; Viala K
Int J Neurosci; 2017 Oct; 127(10):864-872. PubMed ID: 27918219
[TBL] [Abstract][Full Text] [Related]
54. Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.
Jacob S; Rajabally YA
Curr Neuropharmacol; 2009 Dec; 7(4):337-42. PubMed ID: 20514213
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory neuropathies.
Whitesell J
Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
[TBL] [Abstract][Full Text] [Related]
56. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
[TBL] [Abstract][Full Text] [Related]
57. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
58. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options.
Meuth SG; Kleinschnitz C
Eur Neurol; 2010; 63(4):193-204. PubMed ID: 20150737
[TBL] [Abstract][Full Text] [Related]
59. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
60. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
